Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Published online before print December 2, 2002, 10.1148/radiol.2261012140

(Radiology 2003;226:214.)

A more recent version of this article appeared on January 1, 2003
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow All Versions of this Article:
2261012140v1
226/1/214    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bremer, C.
Right arrow Articles by Weissleder, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bremer, C.
Right arrow Articles by Weissleder, R.
© RSNA, 2002

Experimental Studies

Steady-State Blood Volume Measurements in Experimental Tumors with Different Angiogenic Burdens—A Study in Mice1

Christoph Bremer, MD, Mona Mustafa, MD, Alex Bogdanov, Jr, PhD, Vasilis Ntziachristos, PhD, Alexander Petrovsky, MD and Ralph Weissleder, MD, PhD

1 From the Center for Molecular Imaging Research, Massachusetts General Hospital and Harvard Medical School, Bldg 149, 13th St, 5406, Charlestown, MA 02129. Received January 9, 2002; revision requested February 4; revision received April 2; accepted May 23. Address correspondence to R.W. (e-mail: weissleder@helix.mgh.harvard.edu).

PURPOSE: To experimentally validate the effectiveness of magnetic resonance (MR) imaging enhanced with long-circulating iron oxide for measurement of vascular volume fractions (VVFs) as indicators of angiogenesis in different experimental tumor models.

MATERIALS AND METHODS: Tumors with differing degrees of angiogenesis—9L rodent gliosarcoma, DU4475 human mammary adenocarcinoma, HT1080 human fibrosarcoma, and EOMA hemangioendothelioma—were implanted in nude mice. Tumoral VVFs were measured at submillimeter voxel resolutions by using 1.5-T MR imaging. A technetium-labeled intravascular radiotracer was injected into a subset of the animals to validate the MR imaging measurements. Microvessel density and vascular endothelial growth factor (VEGF) also were measured. Statistical analysis was performed with analysis of variance.

RESULTS: High-resolution multisection MR maps of tumor blood volume were obtained in all tumor models. Mean tumoral VVF differed significantly among the different tumors: 2.1% ± 0.3 (standard error of mean) for 9L gliosarcoma, 3.1% ± 0.4 for DU4475 mammary adenocarcinoma, 5.5% ± 0.8 for HT1080 fibrosarcoma, and 6.6% ± 0.9 for EOMA hemangioendothelioma (P < .01). There was a strong correlation between the MR imaging and radiotracer measurements. There was considerable intra- and intertumoral heterogeneity among the VVFs. MR imaging measurements were in accordance with conventional measurements of angiogenesis, such as microvessel density count and VEGF.

CONCLUSION: Measurements of tumoral VVF at high-resolution MR imaging with long-circulating iron oxide are feasible and correlate with angiogenic burden in experimental tumor models.

© RSNA, 2002

Index terms: Angiogenesis • Contrast media, experimental studies • Experimental study • Neoplasms, experimental studies • Neoplasms, radionuclide studies




This article has been cited by other articles:


Home page
 RadiologyHome page
T. Persigehl, R. Bieker, L. Matuszewski, A. Wall, T. Kessler, H. Kooijman, N. Meier, W. Ebert, W. E. Berdel, W. Heindel, et al.
Antiangiogenic Tumor Treatment: Early Noninvasive Monitoring with USPIO-enhanced MR Imaging in Mice
Radiology, August 1, 2007; 244(2): 449 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. C. Pereira, D. E. Huddleston, A. M. Brickman, A. A. Sosunov, R. Hen, G. M. McKhann, R. Sloan, F. H. Gage, T. R. Brown, and S. A. Small
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus
PNAS, March 27, 2007; 104(13): 5638 - 5643.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
X. Montet, J.-L. Figueiredo, H. Alencar, V. Ntziachristos, U. Mahmood, and R. Weissleder
Tomographic Fluorescence Imaging of Tumor Vascular Volume in Mice
Radiology, March 1, 2007; 242(3): 751 - 758.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
L. Matuszewski, T. Persigehl, A. Wall, N. Meier, R. Bieker, H. Kooijman, B. Tombach, R. Mesters, W. E. Berdel, W. Heindel, et al.
Assessment of Bone Marrow Angiogenesis in Patients with Acute Myeloid Leukemia by Using Contrast-enhanced MR Imaging with Clinically Approved Iron Oxides: Initial Experience
Radiology, December 1, 2006; 242(1): 217 - 224.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. J. Kelloff, K. A. Krohn, S. M. Larson, R. Weissleder, D. A. Mankoff, J. M. Hoffman, J. M. Link, K. Z. Guyton, W. C. Eckelman, H. I. Scher, et al.
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
Clin. Cancer Res., November 15, 2005; 11(22): 7967 - 7985.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. R. Kim, A. Yudina, J. Figueiredo, W. Reichardt, D. Hu-Lowe, A. Petrovsky, H. W. Kang, D. Torres, U. Mahmood, R. Weissleder, et al.
Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor
Cancer Res., October 15, 2005; 65(20): 9253 - 9260.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Tang, M. Kim, D. Carrasco, A. L. Kung, L. Chin, and R. Weissleder
In vivo Assessment of RAS-Dependent Maintenance of Tumor Angiogenesis by Real-time Magnetic Resonance Imaging
Cancer Res., September 15, 2005; 65(18): 8324 - 8330.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Kessler, R. Bieker, T. Padro, C. Schwoppe, T. Persigehl, C. Bremer, M. Kreuter, W. E. Berdel, and R. M. Mesters
Inhibition of Tumor Growth by RGD Peptide-Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature
Clin. Cancer Res., September 1, 2005; 11(17): 6317 - 6324.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Montet, V. Ntziachristos, J. Grimm, and R. Weissleder
Tomographic Fluorescence Mapping of Tumor Targets
Cancer Res., July 15, 2005; 65(14): 6330 - 6336.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
L. Matuszewski, T. Persigehl, A. Wall, W. Schwindt, B. Tombach, M. Fobker, C. Poremba, W. Ebert, W. Heindel, and C. Bremer
Cell Tagging with Clinically Approved Iron Oxides: Feasibility and Effect of Lipofection, Particle Size, and Surface Coating on Labeling Efficiency
Radiology, April 1, 2005; 235(1): 155 - 161.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, and J. H. Thrall
Imaging Angiogenesis: Applications and Potential for Drug Development
J Natl Cancer Inst, February 2, 2005; 97(3): 172 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Krix, F. Kiessling, S. Vosseler, N. Farhan, M. M. Mueller, P. Bohlen, N. E. Fusenig, and S. Delorme
Sensitive Noninvasive Monitoring of Tumor Perfusion during Antiangiogenic Therapy by Intermittent Bolus-Contrast Power Doppler Sonography
Cancer Res., December 1, 2003; 63(23): 8264 - 8270.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2002 by the Radiological Society of North America.